Zimmer Biomet Holdings’s Registered Secondary Common Stock Offering
August 12, 2016
Cravath represented the underwriters, Goldman, Sachs & Co. and J.P. Morgan Securities, in connection with the US$965 million registered secondary common stock offering of Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare. The shares were listed on the New York Stock Exchange. The transaction closed on August 12, 2016.
The Cravath team included partners William J. Whelan III and William V. Fogg and associates Lee M. Blum, Martin P. Pepeljugoski and Alan Campbell.
Related Practices & Industries
People
- Photo
-
-
J.D., 1991, Columbia Law SchoolHarlan Fiske Stone Scholar
-
A.B., 1988, Brown Universitymagna cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 1983, Fordham University School of Lawcum laude
-
B.A., 1980, University of Virginiawith Distinction
Education
Related News & Insights
Deals & Cases
December 04, 2024
Zimmer Biomet Holdings, Inc.’s Registered Notes Offering
Cravath represented the underwriters in connection with the €700 million registered notes offering of Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare. The transaction closed on November 20, 2024.
Deals & Cases
December 15, 2023
Zimmer Biomet Holdings, Inc.’s Registered Notes Offering
Cravath represented the underwriters in connection with the $500 million registered notes offering of Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare. The transaction closed on December 1, 2023.
